We are live on ! Find out more
JIP

Jaffetilchin Investment Partners Portfolio holdings

AUM $1.68B
1-Year Est. Return 22.81%
This Fund
S&P 500
This Quarter Est. Return
-9.2%
1 Year Est. Return
+22.81%
3 Year Est. Return
+78.52%
5 Year Est. Return
+93%
10 Year Est. Return
+323.14%
AUM
$400M
AUM Growth
-$73.1M
Cap. Flow
-$27.5M
Cap. Flow %
-6.86%
Top 10 Hldgs %
51.87%
Holding
390
New
91
Increased
73
Reduced
82
Closed
138

Sector Composition

Rank Sector Weight
1 Technology 5.51%
2 Healthcare 3.55%
3 Consumer Discretionary 2.95%
4 Utilities 1.96%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRW
226
Saba Capital Income & Opportunities Fund
BRW
$335M
$227K 0.06%
25,287
-16,059
-39% -$153K
AME icon
227
Ametek
AME
$59.3B
$225K 0.06%
3,325
+444
+15% +$31.9K
SYK icon
228
Stryker
SYK
$133B
$222K 0.06%
1,417
+2
+0.1% +$335
AMTD
229
DELISTED
TD Ameritrade Holding Corp
AMTD
$222K 0.06%
+4,528
New +$231K
AXP icon
230
American Express
AXP
$232B
$220K 0.06%
+2,313
New +$242K
BMY icon
231
Bristol-Myers Squibb
BMY
$130B
$219K 0.05%
4,206
+70
+2% +$3.76K
REGN icon
232
Regeneron Pharmaceuticals
REGN
$82.2B
$219K 0.05%
586
-2,595
-82% -$950K
MOS icon
233
The Mosaic Company
MOS
$7.18B
$216K 0.05%
+7,385
New +$243K
SBUX icon
234
Starbucks
SBUX
$124B
$215K 0.05%
+3,339
New +$209K
DXC icon
235
DXC Technology
DXC
$1.71B
$213K 0.05%
4,002
-482
-11% -$33.3K
TECD
236
DELISTED
Tech Data Corp
TECD
$212K 0.05%
2,592
-2,528
-49% -$192K
EBS icon
237
Emergent Biosolutions
EBS
$233M
$211K 0.05%
+3,552
New +$229K
IPG
238
DELISTED
Interpublic Group of Companies
IPG
$209K 0.05%
+10,143
New +$232K
TMO icon
239
Thermo Fisher Scientific
TMO
$223B
$209K 0.05%
+935
New +$219K
CI icon
240
Cigna
CI
$73.3B
$207K 0.05%
+1,090
New +$227K
DAL icon
241
Delta Air Lines
DAL
$59.1B
$206K 0.05%
+4,121
New +$224K
FUTY icon
242
Fidelity MSCI Utilities Index ETF
FUTY
$2.31B
$204K 0.05%
+5,851
New +$209K
URTH icon
243
iShares MSCI World ETF
URTH
$8.35B
$203K 0.05%
+2,578
New +$219K
BA icon
244
Boeing
BA
$183B
$202K 0.05%
627
-2,875
-82% -$993K
CTAS icon
245
Cintas
CTAS
$81.4B
$201K 0.05%
4,788
-8,316
-63% -$372K
OPK icon
246
Opko Health
OPK
$1.04B
$102K 0.03%
34,025
-1,275,110
-97% -$4.32M
NBR icon
247
Nabors Industries
NBR
$1.33B
$36K 0.01%
359
-1,029
-74% -$227K
ADYX
248
DELISTED
Adynxx Inc
ADYX
$29K 0.01%
2,584
WFT
249
DELISTED
Weatherford International plc
WFT
$26K 0.01%
+45,826
New +$59.8K
UPL
250
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$14K ﹤0.01%
+18,500
New +$23.4K

Similar funds

Jaffetilchin Investment Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Jaffetilchin Investment Partners held 390 positions worth $400M, down 15% from $473M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Jaffetilchin Investment Partners withdrew a net $27.5M in Q4 2018, closing 138 positions and reducing 82 holdings. Its most notable exit was Vanguard Russell 2000 ETF, an estimated $8.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jaffetilchin Investment Partners opened a new position in JPMorgan Ultra-Short Income ETF worth $46.9M.

  • Jaffetilchin Investment Partners's largest Q4 2018 buy was JPMorgan Ultra-Short Income ETF: 934,915 shares worth $46.9M.
  • Jaffetilchin Investment Partners added most to iShares Core S&P Total US Stock Market ETF in Q4 2018, an estimated $4.14M increase.
  • Jaffetilchin Investment Partners's biggest Q4 2018 reduction was iShares Core MSCI Total International Stock ETF, cutting an estimated $6.54M.
  • Jaffetilchin Investment Partners fully exited Vanguard Russell 2000 ETF in Q4 2018, selling an estimated $8.52M.
  • Jaffetilchin Investment Partners's ten largest holdings make up 52% of its $400M portfolio in Q4 2018.
  • Jaffetilchin Investment Partners opened 91 new positions and closed 138 in Q4 2018.
  • Jaffetilchin Investment Partners's portfolio value fell 15% quarter-over-quarter to $400M.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2018, filed 11 Feb 2019.